Koji Okamoto

10.7k total citations · 4 hit papers
187 papers, 8.0k citations indexed

About

Koji Okamoto is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Koji Okamoto has authored 187 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Molecular Biology, 49 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in Koji Okamoto's work include Cancer-related Molecular Pathways (19 papers), Cancer Cells and Metastasis (18 papers) and Ubiquitin and proteasome pathways (16 papers). Koji Okamoto is often cited by papers focused on Cancer-related Molecular Pathways (19 papers), Cancer Cells and Metastasis (18 papers) and Ubiquitin and proteasome pathways (16 papers). Koji Okamoto collaborates with scholars based in Japan, United States and United Kingdom. Koji Okamoto's co-authors include Janet M. Shaw, David Beach, Yasutake Teraoka, Noboru Yamazoe, Hiroshi Hamada, Hitoshi Okazawa, Hirokazu Ohata, Yoichi Taya, Masami Muramatsu and Ai Sato and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Koji Okamoto

172 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells

1990 632 citations Koji Okamoto et al. profile →
Mitochondrial Morphology and Dynamics in Yeast and Multicellular Eukaryotes

2005 597 citations Koji Okamoto et al. profile →
Mixed ionic-electronic conductivity of La1−xSrxCo1−yFeyO3−δ perovskite-type oxides

1988 532 citations Koji Okamoto et al. profile →
Tumor‐derived spheroids: Relevance to cancer stem cells and clinical applications

2017 388 citations Tatsuya Ishiguro, Hirokazu Ohata et al. Cancer Science profile →

Peers

Countries citing papers authored by Koji Okamoto

Since Specialization

Citations

This map shows the geographic impact of Koji Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Okamoto more than expected).

Fields of papers citing papers by Koji Okamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Okamoto. The network helps show where Koji Okamoto may publish in the future.

Co-authorship network of co-authors of Koji Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Okamoto. A scholar is included among the top collaborators of Koji Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Okamoto. Koji Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of wettability and particle size on aerosol removal efficiency in charged and neutral water spray systems 2025 ·Journal of environmental chemical engineering ·Zeeshan Ahmed, Ravinder Kumar, (unknown), Ruicong Xu, Shuichiro Miwa, Koji Okamoto, Shunichi Suzuki	4
2	Efficient radioactive aerosol removal with the development of water mist pre-injection methods and advanced spray charging system for safe Fukushima Daiichi decommissioning: insights from recent experimental studies in UTARTS facility 2025 ·Journal of Nuclear Science and Technology ·Ruicong Xu, (unknown), Ravinder Kumar, Zeeshan Ahmed, R. Yokoyama, Shuichiro Miwa, Shunichi Suzuki, Koji Okamoto	4
3	Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma Developing Renal AA Amyloidosis: A Case Report and Literature Review 2025 ·Internal Medicine ·(unknown), Yuji Oe, (unknown), (unknown), Yuji Noguchi, Kôichi Kikuchi, (unknown), (unknown), Koji Okamoto, Tasuku Nagasawa, Takafumi Toyohara, Mariko Miyazaki, Hiroshi Sato, Yasushi Onishi, Hitoshi Warita, Tetsuhiro Tanaka	0
4	Development of an industry-applicable two-phase flow regime identification approach using flow-induced vibration acceleration signals 2025 ·Engineering Applications of Artificial Intelligence ·(unknown), Shuichiro Miwa, (unknown), Takashi Hibiki, Koji Okamoto	2
5	Glycolysis-mTORC1 crosstalk drives proliferation of patient-derived endometrial cancer spheroid cells with ALDH activity 2024 ·Cell Death Discovery ·Haruka Ueda, Tatsuya Ishiguro, Yutaro Mori, Kaoru Yamawaki, Koji Okamoto, Takayuki Enomoto, Kosuke Yoshihara	0
6	PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy 2023 ·eLife ·Teruhiko Yoshida, (unknown), Avi Z. Rosenberg, (unknown), Komuraiah Myakala, Yu Ishimoto, Yongmei Zhao, Shashi Shrivastav, Bryce A. Jones, Xiaoping Yang, Xiaoxin X. Wang, (unknown), Pinaki Sarder, Moshe Levi, Koji Okamoto, Cheryl A. Winkler, Jeffrey B. Kopp	3
7	Effect of Blonanserin on the Proliferation and Migration of Glioblastoma Cells. 2023 ·PubMed ·Naoto Tsuchiya, Koji Okamoto, Shinichi Nakao, Satoshi Ohmori, Tadashi Shimizu	2
8	Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ 2022 ·Cancer Research ·(unknown), Jun Nakayama, Marta Prieto‐Vila, Sho Shiino, (unknown), Tomofumi Yamamoto, Naoaki Watanabe, Shin Takayama, Yutaka Suzuki, Koji Okamoto, Takahiro Ochiya, Takashi Kohno, (unknown), Akihiko Suto, Yusuke Yamamoto	18
9	Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma 2021 ·Oncogene ·(unknown), Takeshi Namekawa, Kazuhiro Ikeda, Takashi Suzuki, (unknown), Hideki Takeshita, Akihiro Yano, Koji Okamoto, Tomohiko Ichikawa, Kuniko Horie‐Inoue, Satoru Kawakami, Satoshi Inoue	18
10	Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer 2021 ·Cancer Science ·Toshiaki Miyazaki, Suyoun Chung, Hiroaki Sakai, Hirokazu Ohata, Yuuki Obata, Daisuke Shiokawa, (unknown), Takashi Kubo, Hitoshi Ichikawa, Hirokazu Taniguchi, Kazunori Aoki, Tomoyoshi Soga, Hitoshi Nakagama, Koji Okamoto	43
11	Slow-Cycling Cancer Stem Cells Regulate Progression and Chemoresistance in Colon Cancer 2020 ·Cancer Research ·Daisuke Shiokawa, Hiroaki Sakai, Hirokazu Ohata, Toshiaki Miyazaki, Yusuke Kanda, Shigeki Sekine, Daichi Narushima, Masahito Hosokawa, Mamoru Kato, Yutaka Suzuki, Haruko Takeyama, Hideki Kambara, Hitoshi Nakagama, Koji Okamoto	60
12	Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity 2015 ·Cancer Research ·Tatsuya Ishiguro, Ai Sato, Hirokazu Ohata, Yoshinori Ikarashi, Ryou-u Takahashi, Takahiro Ochiya, Masayuki Yoshida, Hitoshi Tsuda, Takashi Onda, Tomoyasu Kato, Takahiro Kasamatsu, Takayuki Enomoto, Kenichi Tanaka, Hitoshi Nakagama, Koji Okamoto	58
13	Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer–Initiating Cells 2012 ·Cancer Research ·Hirokazu Ohata, Tatsuya Ishiguro, (unknown), Ai Sato, Hiroaki Sakai, Shigeki Sekine, Hirokazu Taniguchi, Takayuki Akasu, Shin Fujita, Hitoshi Nakagama, Koji Okamoto	93
14	Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21 2011 ·Cancer Research ·Naoto Tsuchiya, Masashi Izumiya, Hiroko Ogata‐Kawata, Koji Okamoto, Yuko Fujiwara, (unknown), Atsushi Okabe, Aaron J. Schetter, Elise D. Bowman, Yutaka Midorikawa, Yasuyuki Sugiyama, Hiroyuki Aburatani, Curtis C. Harris, Hitoshi Nakagama	101
15	Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2 2008 ·Proceedings of the National Academy of Sciences ·Yoshinori Abe, (unknown), Kei Tobiume, Keiko Kawauchi, Yoichi Taya, Koji Okamoto, Moshe Oren, Nobuyuki Tanaka	113
16	Chapter 16 Targeting of green fluorescent protein to mitochondria 2001 ·Methods in cell biology ·Koji Okamoto, Philip S. Perlman, Ronald A. Butow	21
17	Characterization of aDictyosteliumFactor That Acts Synergistically with DIF to Induce Terminal Stalk Cell Differentiation 1997 ·Developmental Biology ·Yoko Yamada, Koji Okamoto, Jeffrey G. Williams	9
18	A Case of Malignant Melanoma in the Japanese Black Calf 1995 ·Journal of the Japan Veterinary Medical Association ·Akihiro Oishi, Yasuho TAURA, (unknown), Tsutomu Shimizu, Koji Okamoto	0
19	Multicentric carcinoma in the oral cavity and pharynx; A report of eight cases. 1990 ·Practica Oto-Rhino-Laryngologica ·Koji Okamoto, Kayoko Sato, (unknown), Satoshi Koike	1
20	Anodic Oxidation of Some Bromophenols : Syntheses of Highly Brominated Diphenyl Ethers and Related Compounds(Organic,Chemical) 1986 ·Chemical and Pharmaceutical Bulletin ·Masanobu Iguchi, Atsuko Nishiyama, Hideo Etoh, Koji Okamoto, Shosuke Yamamura, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact